Prostate Cancer Drug Resistance Mediated by Epigenetic Changes

Epigenetic changes in the tumor microenvironment may explain why prostate cancer patients develop resistance to androgen signaling deprivation therapy.

from Latest articles from Cancer Therapy Advisor Male Reproductive Cancers https://ift.tt/2DoPsHx